Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Debt Ratio (2017 - 2021)

Sunshine Biopharma filings provide 5 years of Debt Ratio readings, the most recent being 0.86 for Q4 2021.

  • On a quarterly basis, Debt Ratio fell 4.98% to 0.86 in Q4 2021 year-over-year; TTM through Dec 2021 was 0.86, a 4.98% decrease, with the full-year FY2021 number at 0.86, down 4.98% from a year prior.
  • Debt Ratio hit 0.86 in Q4 2021 for Sunshine Biopharma, down from 1.28 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.28 in Q3 2021 to a low of 0.19 in Q3 2019.
  • Median Debt Ratio over the past 5 years was 0.46 (2020), compared with a mean of 0.61.
  • Biggest five-year swings in Debt Ratio: plummeted 33.5% in 2019 and later skyrocketed 245.09% in 2020.
  • Sunshine Biopharma's Debt Ratio stood at 0.31 in 2017, then decreased by 12.46% to 0.27 in 2018, then crashed by 30.55% to 0.19 in 2019, then skyrocketed by 382.31% to 0.91 in 2020, then dropped by 4.98% to 0.86 in 2021.
  • The last three reported values for Debt Ratio were 0.86 (Q4 2021), 1.28 (Q3 2021), and 1.13 (Q2 2021) per Business Quant data.